Cindy Zuleger

581 total citations
26 papers, 426 citations indexed

About

Cindy Zuleger is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Cindy Zuleger has authored 26 papers receiving a total of 426 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 10 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Cindy Zuleger's work include Immunotherapy and Immune Responses (19 papers), CAR-T cell therapy research (9 papers) and T-cell and B-cell Immunology (6 papers). Cindy Zuleger is often cited by papers focused on Immunotherapy and Immune Responses (19 papers), CAR-T cell therapy research (9 papers) and T-cell and B-cell Immunology (6 papers). Cindy Zuleger collaborates with scholars based in United States, Switzerland and Chile. Cindy Zuleger's co-authors include Lendon G. Payne, Dexiang Chen, Mark R. Albertini, Qili Chu, Jorge E. Osorio, Melissa Burger, Paul M. Sondel, Jacquelyn A. Hank, Michael D. Macklin and Jacek Gan and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Journal of Virology.

In The Last Decade

Cindy Zuleger

25 papers receiving 398 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cindy Zuleger United States 13 257 142 95 69 60 26 426
Gerd Rechtsteiner Germany 10 608 2.4× 189 1.3× 108 1.1× 107 1.6× 26 0.4× 12 767
Genevieve Weir Canada 14 322 1.3× 175 1.2× 183 1.9× 99 1.4× 21 0.3× 37 529
Oscar Haigh France 11 237 0.9× 124 0.9× 120 1.3× 95 1.4× 19 0.3× 39 520
Maxim Pavlenko Sweden 10 313 1.2× 173 1.2× 94 1.0× 48 0.7× 104 1.7× 12 430
Deepa Mohanan Switzerland 9 296 1.2× 156 1.1× 48 0.5× 54 0.8× 10 0.2× 11 490
Jessica C. Lee United States 7 195 0.8× 92 0.6× 63 0.7× 119 1.7× 60 1.0× 11 369
Lorna Rettig Switzerland 7 245 1.0× 142 1.0× 100 1.1× 14 0.2× 11 0.2× 7 361
Jessica Jeang United States 6 271 1.1× 152 1.1× 123 1.3× 118 1.7× 34 0.6× 7 393
Kimberly A. Kraynyak United States 14 212 0.8× 132 0.9× 98 1.0× 115 1.7× 45 0.8× 28 413
Fushun Shi United States 11 188 0.7× 147 1.0× 110 1.2× 19 0.3× 57 0.9× 13 363

Countries citing papers authored by Cindy Zuleger

Since Specialization
Citations

This map shows the geographic impact of Cindy Zuleger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cindy Zuleger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cindy Zuleger more than expected).

Fields of papers citing papers by Cindy Zuleger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cindy Zuleger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cindy Zuleger. The network helps show where Cindy Zuleger may publish in the future.

Co-authorship network of co-authors of Cindy Zuleger

This figure shows the co-authorship network connecting the top 25 collaborators of Cindy Zuleger. A scholar is included among the top collaborators of Cindy Zuleger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cindy Zuleger. Cindy Zuleger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Albertini, Mark R., Cindy Zuleger, Erik A. Ranheim, et al.. (2024). Administration of intratumoral GD2-directed interleukin-2 immunocytokine and local radiation therapy to activate immune rejection of spontaneous canine melanoma. Melanoma Research. 34(4). 307–318. 3 indexed citations
2.
Jin, Won Jong, Justin C. Jagodinsky, Paul A. Clark, et al.. (2023). NK cells propagate T cell immunity following in situ tumor vaccination. Cell Reports. 42(12). 113556–113556. 8 indexed citations
3.
4.
Marsh, Ian R., Michelle Turek, Joseph J. Grudzinski, et al.. (2021). Safety and feasibility of an in situ vaccination and immunomodulatory targeted radionuclide combination immuno-radiotherapy approach in a comparative (companion dog) setting. PLoS ONE. 16(8). e0255798–e0255798. 20 indexed citations
5.
Yang, Richard K., Igor B. Kuznetsov, Erik A. Ranheim, et al.. (2020). Outcome-Related Signatures Identified by Whole Transcriptome Sequencing of Resectable Stage III/IV Melanoma Evaluated after Starting Hu14.18-IL2. Clinical Cancer Research. 26(13). 3296–3306. 17 indexed citations
6.
Albertini, Mark R., Richard K. Yang, Erik A. Ranheim, et al.. (2018). Pilot trial of the hu14.18-IL2 immunocytokine in patients with completely resectable recurrent stage III or stage IV melanoma. Cancer Immunology Immunotherapy. 67(10). 1647–1658. 36 indexed citations
7.
Zuleger, Cindy, Erik A. Ranheim, Ilene D. Kurzman, et al.. (2017). Pilot study of safety and feasibility of DNA microseeding for treatment of spontaneous canine melanoma. Veterinary Medicine and Science. 3(3). 134–145. 10 indexed citations
8.
Albertini, Mark R., Erik A. Ranheim, Cindy Zuleger, et al.. (2016). Phase I study to evaluate toxicity and feasibility of intratumoral injection of α-gal glycolipids in patients with advanced melanoma. Cancer Immunology Immunotherapy. 65(8). 897–907. 14 indexed citations
9.
Zuleger, Cindy & Mark R. Albertini. (2012). OMIP‐008: Measurement of Th1 and Th2 cytokine polyfunctionality of human T cells. Cytometry Part A. 81A(6). 450–452. 8 indexed citations
10.
Bhatia, Neehar, Imtiaz A. Siddiqui, Saravanan Thiyagarajan, et al.. (2012). MAGE-C2 Promotes Growth and Tumorigenicity of Melanoma Cells, Phosphorylation of KAP1, and DNA Damage Repair. Journal of Investigative Dermatology. 133(3). 759–767. 49 indexed citations
11.
Zuleger, Cindy, Michael D. Macklin, Bret L. Bostwick, et al.. (2010). In vivo 6-thioguanine-resistant T cells from melanoma patients have public TCR and share TCR beta amino acid sequences with melanoma-reactive T cells. Journal of Immunological Methods. 365(1-2). 76–86. 4 indexed citations
12.
Albertini, Mark R., et al.. (2008). Clonal expansions of 6‐thioguanine resistant T lymphocytes in the blood and tumor of melanoma patients. Environmental and Molecular Mutagenesis. 49(9). 676–687. 6 indexed citations
13.
Maa, Yuh‐Fun, Mahmoud Ameri, Cindy Zuleger, et al.. (2006). Hepatitis-B Surface Antigen (HBsAg) Powder Formulation: Process and Stability Assessment. Current Drug Delivery. 4(1). 57–67. 14 indexed citations
14.
Zuleger, Cindy, Xiaoyan Gao, Melissa Burger, et al.. (2005). Peptide induces CD4+CD25+ and IL-10+ T cells and protection in airway allergy models. Vaccine. 23(24). 3181–3186. 19 indexed citations
15.
Chen, Dexiang, Melissa Burger, Qili Chu, et al.. (2004). Epidermal powder immunization: cellular and molecular mechanisms for enhancing vaccine immunogenicity. Virus Research. 103(1-2). 147–153. 17 indexed citations
16.
Burger, Melissa, Cindy Zuleger, Qili Chu, et al.. (2004). An antigen-independent but not antigen-specific TH1 response provides protection in the murine airway inflammation model. Journal of Allergy and Clinical Immunology. 114(6). 1301–1308. 11 indexed citations
17.
Osorio, Jorge E., Cindy Zuleger, Melissa Burger, et al.. (2003). Immune responses to hepatitis B surface antigen following epidermal powder immunization. Immunology and Cell Biology. 81(1). 52–58. 23 indexed citations
18.
Maa, Yuh‐Fun, Mahmoud Ameri, Cindy Zuleger, et al.. (2003). Optimization of an Alum-Adsorbed Vaccine Powder Formulation for Epidermal Powder Immunization. Pharmaceutical Research. 20(7). 969–977. 21 indexed citations
19.
Chen, Daxin, et al.. (2002). Epidermal Powder Immunization with a Recombinant HIV gp120 Targets Langerhans Cells and Induces Enhanced Immune Responses. AIDS Research and Human Retroviruses. 18(10). 715–722. 26 indexed citations
20.
Chen, Dexiang, et al.. (2001). Serum and Mucosal Immune Responses to an Inactivated Influenza Virus Vaccine Induced by Epidermal Powder Immunization. Journal of Virology. 75(17). 7956–7965. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gerd Rechtsteiner Breakdown of academic impact, for papers by Genevieve Weir Breakdown of academic impact, for papers by Oscar Haigh Breakdown of academic impact, for papers by Maxim Pavlenko Breakdown of academic impact, for papers by Deepa Mohanan Breakdown of academic impact, for papers by Jessica C. Lee Breakdown of academic impact, for papers by Lorna Rettig Breakdown of academic impact, for papers by Jessica Jeang Breakdown of academic impact, for papers by Kimberly A. Kraynyak Breakdown of academic impact, for papers by Fushun Shi
Rankless by CCL
2026